is associated with poor quality of life. Voiding and sleep patterns should be strictly evaluated in elderly patients to define which of urological disease or sleep disorder is primitive factor. Various medical options to control voiding and/or storage symptoms with sleep disorder have chosen as monotherapy or combination therapy including alphablockers, anticholinergics and antidiuretic hormone for urinary symptoms as well as good sleep hygiene practice of sleep disorder and hypnotics for insomnia. Therefore, to clarify underlying disease to cause patient's chief complaint is essential resulting to maximize therapeutic results. This lecture will provide pathogenesis, diagnostic approach, ideal pharmacologic treatment with underlying action mechanism and cognitive behavior therapy in elderly with simultaneous sleep disorder and urological disease. Abstract: Inflatable penile prostheses (IPP) have been utilized reliably as a definitive treatment for medically refractory erectile dysfunction (ED) over the last four decades. The device consists of two intra-corporal penile cylinders, a pump placed in the scrotum, and a fluidcontaining reservoir. However, placement of an IPP reservoir in a patient with multiple lower abdominal/ pelvic surgeries is technique challenge. The Conceal low profile reservoir and Cloverleaf are designs to allow ectopic placement and to avoid potential bladder, bowel or vascular injury. Another rare but potentially devastating complication of IPP implantation is infection of the implant. In the event that an implant becomes infected, all components of the IPP need to be removed. Removal of reservoir has also been surgically challenging due to its location; either deep in the space of Retzius of the pelvis or high in the abdomen between the muscular fascia. This presentation will discuss new strategy for IPP reservoir placement and removal.
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Conclusions:
For patients with non-iatrogenic nontraumatic OA receiving scrotal exploration, 28.1% are not eligible for correction. The mean patency rates for all patients 6 months after micro-anastomosis were 79.5%. They were 90.9% and 88% for cases with obstruction at bilateral epididymal tails and body respectively. Motile sperm in proximal end predicts higher patency rates. AB024. Safety evaluation of low-energy extracorporeal shock wave therapy to rat testes
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Background: The purpose of the study is to determine the optimal energy frequency of LESWT to rat testes by comparing three different shock wave frequencies. Methods: A total of 40 healthy Sprague-Dawley (SD) rats were randomly assigned to a blank group (C group) in which 5 rats received no treatment, a sham group (B group) in which 5 rats only exposed to shockwave, and LESWT groups (A group) in which 30 rats separately exposed to 0.02 mJ/mm 2 (A1 group), 0.04 mJ/mm 2 (A2 group), and 0.06 mJ/mm 2 (A3 group). The changes of rat weight among these five groups were compared. Eenzyme-linked immunosorbent assay (ELISA) was performed to measure the concentrations of testosterone (T), luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Testicular mass index (TMI) of rat bilateral testes was compared. A transmission electron microscopy (TEM) was used to observe the microstructure of testes in rats among five groups. Results: After a 2-week period of low-energy extracorporeal shock wave therapy (LESWT), the rat weight changed significantly between A1 and A3 groups but did not differ among A1, A2, B, and C groups (P=0.09, 0.31, 0.47); no significant difference in T, LH, and FSH concentrations was observed when the A1 group was respectively compared with other four groups (P=0.11, 0.33, 0.19, 0.47) ; the TMI of rat testes in the A1 group was significantly different from that in the A3 group (P=0.04). Observations from the TEM showed that rats exhibited normal microstructure of testes in A1, B, and C groups. Mitochondrial swelling, dissolution of cristae, and dilated intercellular space occurred in the A2 group. Mitochondrial vacuolization, nuclear perturbations, cytoplasmic segregation, and necrotic cells were observed in the A3 group. Conclusions: Taken together, we conclude that 0.02 mJ/mm
